Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate effectively treats female hair loss by increasing healthy hair and decreasing unhealthy hair, but doesn't change hair thickness.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Baricitinib successfully treated severe hair loss.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Different medications can cause serious side effects in some people.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Valproic acid can cause hair color change in older men.

Valproic acid can very rarely cause nail separation, which usually gets better on its own after stopping the drug.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

ARWH is a rare hair disorder with no cure, but potential treatments include minoxidil and other therapies.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Baricitinib significantly regrows hair in severe alopecia areata patients.